These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
365 related articles for article (PubMed ID: 22992049)
1. Synthesis of new 4-thiazolidinone-, pyrazoline-, and isatin-based conjugates with promising antitumor activity. Havrylyuk D; Zimenkovsky B; Vasylenko O; Gzella A; Lesyk R J Med Chem; 2012 Oct; 55(20):8630-41. PubMed ID: 22992049 [TBL] [Abstract][Full Text] [Related]
2. Synthesis and anticancer activity of isatin-based pyrazolines and thiazolidines conjugates. Havrylyuk D; Kovach N; Zimenkovsky B; Vasylenko O; Lesyk R Arch Pharm (Weinheim); 2011 Aug; 344(8):514-22. PubMed ID: 21681810 [TBL] [Abstract][Full Text] [Related]
3. Synthesis of 1-substituted 3-aryl-5-aryl(hetaryl)-2-pyrazolines and study of their antitumor activity. Insuasty B; Chamizo L; Muñoz J; Tigreros A; Quiroga J; Abonía R; Nogueras M; Cobo J Arch Pharm (Weinheim); 2012 Apr; 345(4):275-86. PubMed ID: 22105771 [TBL] [Abstract][Full Text] [Related]
4. Synthesis of novel thiazolone-based compounds containing pyrazoline moiety and evaluation of their anticancer activity. Havrylyuk D; Zimenkovsky B; Vasylenko O; Zaprutko L; Gzella A; Lesyk R Eur J Med Chem; 2009 Apr; 44(4):1396-404. PubMed ID: 19000643 [TBL] [Abstract][Full Text] [Related]
5. QSAR modeling, synthesis and bioassay of diverse leukemia RPMI-8226 cell line active agents. Katritzky AR; Girgis AS; Slavov S; Tala SR; Stoyanova-Slavova I Eur J Med Chem; 2010 Nov; 45(11):5183-99. PubMed ID: 20843586 [TBL] [Abstract][Full Text] [Related]
6. Synthesis and in vitro evaluation of some isatin-thiazolidinone hybrid analogues as anti-proliferative agents. Ramshid PK; Jagadeeshan S; Krishnan A; Mathew M; Nair SA; Pillai MR Med Chem; 2010 Sep; 6(5):306-12. PubMed ID: 21073435 [TBL] [Abstract][Full Text] [Related]
7. Synthesis of novel pyrazolic analogues of chalcones and their 3-aryl-4-(3-aryl-4,5-dihydro-1H-pyrazol-5-yl)-1-phenyl-1H-pyrazole derivatives as potential antitumor agents. Insuasty B; Tigreros A; Orozco F; Quiroga J; Abonía R; Nogueras M; Sanchez A; Cobo J Bioorg Med Chem; 2010 Jul; 18(14):4965-74. PubMed ID: 20594863 [TBL] [Abstract][Full Text] [Related]
8. Polysubstituted pyrazoles, part 6. Synthesis of some 1-(4-chlorophenyl)-4-hydroxy-1H-pyrazol-3-carbonyl derivatives linked to nitrogenous heterocyclic ring systems as potential antitumor agents. Rostom SA Bioorg Med Chem; 2010 Apr; 18(7):2767-76. PubMed ID: 20207545 [TBL] [Abstract][Full Text] [Related]
9. Synthesis of novel 1H-1,2,3-triazole tethered C-5 substituted uracil-isatin conjugates and their cytotoxic evaluation. Kumar K; Sagar S; Esau L; Kaur M; Kumar V Eur J Med Chem; 2012 Dec; 58():153-9. PubMed ID: 23124212 [TBL] [Abstract][Full Text] [Related]
10. Synthesis and evaluation of anticancer activity of some novel 6-aryl-2-(p-sulfamylphenyl)-pyridazin-3(2H)-ones. Rathish IG; Javed K; Ahmad S; Bano S; Alam MS; Akhter M; Pillai KK; Ovais S; Samim M Eur J Med Chem; 2012 Mar; 49():304-9. PubMed ID: 22305543 [TBL] [Abstract][Full Text] [Related]
11. Synthesis, molecular docking and evaluation of thiazolyl-pyrazoline derivatives as EGFR TK inhibitors and potential anticancer agents. Lv PC; Li DD; Li QS; Lu X; Xiao ZP; Zhu HL Bioorg Med Chem Lett; 2011 Sep; 21(18):5374-7. PubMed ID: 21802290 [TBL] [Abstract][Full Text] [Related]
12. 3,5-bis(3'-indolyl)pyrazoles, analogues of marine alkaloid nortopsentin: synthesis and antitumor properties. Diana P; Carbone A; Barraja P; Martorana A; Gia O; DallaVia L; Cirrincione G Bioorg Med Chem Lett; 2007 Nov; 17(22):6134-7. PubMed ID: 17911018 [TBL] [Abstract][Full Text] [Related]
13. Benzimidazole bearing oxadiazole and triazolo-thiadiazoles nucleus: design and synthesis as anticancer agents. Husain A; Rashid M; Mishra R; Parveen S; Shin DS; Kumar D Bioorg Med Chem Lett; 2012 Sep; 22(17):5438-44. PubMed ID: 22840417 [TBL] [Abstract][Full Text] [Related]
14. Novel 1,3,4-heterodiazole analogues: synthesis and in-vitro antitumor activity. Taher AT; Georgey HH; El-Subbagh HI Eur J Med Chem; 2012 Jan; 47(1):445-51. PubMed ID: 22119151 [TBL] [Abstract][Full Text] [Related]
15. Synthesis of new pyrazole derivatives and their anticancer evaluation. Nitulescu GM; Draghici C; Missir AV Eur J Med Chem; 2010 Nov; 45(11):4914-9. PubMed ID: 20728965 [TBL] [Abstract][Full Text] [Related]
16. Quinols as novel therapeutic agents. 2.(1) 4-(1-Arylsulfonylindol-2-yl)-4-hydroxycyclohexa-2,5-dien-1-ones and related agents as potent and selective antitumor agents. Berry JM; Bradshaw TD; Fichtner I; Ren R; Schwalbe CH; Wells G; Chew EH; Stevens MF; Westwell AD J Med Chem; 2005 Jan; 48(2):639-44. PubMed ID: 15658878 [TBL] [Abstract][Full Text] [Related]
17. Synthesis, evaluation of anticancer activity and COMPARE analysis of N-bis(trifluoromethyl)alkyl-N'-substituted ureas with pharmacophoric moieties. Luzina EL; Popov AV Eur J Med Chem; 2012 Jul; 53():364-73. PubMed ID: 22538016 [TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological activity evaluation of 5-pyrazoline substituted 4-thiazolidinones. Havrylyuk D; Zimenkovsky B; Vasylenko O; Day CW; Smee DF; Grellier P; Lesyk R Eur J Med Chem; 2013 Aug; 66():228-37. PubMed ID: 23811085 [TBL] [Abstract][Full Text] [Related]
19. Synthesis of 1H-pyrazole-1-carboxamide derivatives and their antiproliferative activity against melanoma cell line. El-Gamal MI; Sim TB; Hong JH; Cho JH; Yoo KH; Oh CH Arch Pharm (Weinheim); 2011 Mar; 344(3):197-204. PubMed ID: 21384419 [TBL] [Abstract][Full Text] [Related]
20. Synthesis of novel 3,5-diaryl pyrazole derivatives using combinatorial chemistry as inhibitors of tyrosinase as well as potent anticancer, anti-inflammatory agents. Bandgar BP; Totre JV; Gawande SS; Khobragade CN; Warangkar SC; Kadam PD Bioorg Med Chem; 2010 Aug; 18(16):6149-55. PubMed ID: 20638287 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]